Physical Illness and Schizophrenia

A Review of the Evidence

Physical Illness and Schizophrenia

It is well established that people suffering from schizophrenia have a higher prevalence of serious physical illness and a higher mortality than the general population. This book provides the first comprehensive and systematic review of current research evidence on the prevalence of physical diseases in people with schizophrenia, a disorder afflicting approximately 1% of the global population, and a group with mortality rates twice as high as the general population. The epidemiological data described in this book will provide the basis for improved awareness of these problems and better treatment for patients. This is the first in a series of books addressing an issue emerging as a priority in the mental health field: the timely and proper recognition of physical health problems in people with mental disorders. They should be read by policy makers, service managers, mental health professionals and general practitioners.


 Reviews:

"This is a highly valuable review of the available literature on a greatly underappreciated topic. It is likely that this book will become a source document for many future efforts in the long road ahead to improve the status of prevention and treatment for physical health conditions in individuals with major mental disorders like schizophrenia. From this perspective, the book is an important starting place for any discussion of how we can do better in the prevention of disease for this population." PsycCRITIQUES

"This book will be particularly useful for those doing research on co-occurring medical illness and those researching schizophrenia both in psychiatry and in general medicine. Those involved in public policy regarding service delivery and research funding will find a wealth of information, as well as an appreciation for the limits of our current knowledge." - Marie Hobart, Psychiatric Services

'… beyond its enormous merit in giving more salience to the issue of physical comorbidity in patients with schizophrenia, the book of Leuch et al. will hopefully ignite a new global research offensive in this field. The book is certainly uniquely suited to achieving this task.' Journal of Psychosomatic Research

Reference Title: References

Reference Type: reference-list

Reference Type: reference-list

Abraham, G., Paing, W. W., Kaminski, J., et al. (2003) Effects of elevated serum prolactin on bone mineral density and bone metabolism in female patients with schizophrenia: a prospective study. Am. J. Psychiatry 160, 1618–1620.
Adams, P. F., Marano, M. A. (1995) Current estimates for the National Health Interview Survey, 1994. Vital Health Stat. 10, 1–260.
Aizenberg, D., Zemishlany, Z., Dorfman-Etrog, P., Weizman, A. (1995) Sexual dysfunction in male schizophrenic patients. J. Clin. Psychiatry 56, 137–141.
Aleman, A., Kahn, R. S., Selten, J. P. (2003) Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch. Gen. Psychiatry 60, 565–571.
Allebeck, P. (1989) Schizophrenia: a life-shortening disease. Schizophr. Bull. 15, 81–89.
Allebeck, P., Rodvall, Y., Wistedt, B. (1985) Incidence of rheumatoid arthritis among patients with schizophrenia, affective psychosis and neurosis. Acta Psychiatr. Scand. 71, 615–619.
Allison, D. B., Fontaine, K. R., Heo, M., et al. (1999a) The distribution of body mass index among individuals with and without schizophrenia. J. Clin. Psychiatry 60, 215–220.
Allison, D. B., Mentore, J. L., Heo, M., et al. (1999b) Antipsychotic-induced weight gain: a comprehensive research synthesis. Am. J. Psychiatry 156, 1686–1696.
Alvarez, L. M., Castillo, S. T., Perez Zuno, J. A., et al. (1995) [Activity of aryl sulfatase A enzyme in patients with schizophrenic disorders]. Rev. Invest. Clin. 47, 387–392.
American Diabetes Association (2006) Clinical practice recommendations. Diabetes Care 29. Available online at http://care.diabetesjournals.org/content/vol29/suppl_1/.
American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity (2004) Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27, 596–601.
Apostolakis, M., Kapetanakis, S. (1972) Plasma prolactin activity in patients with galactorrhea after treatment with psychotropic drugs. In Lactogenic Hormones, ed. G. E. W. Wolstenholme and J. Knight. Baltimore, MD: Williams and Wilkins, pp. 349–359.
Arce, C. R., Baca-Garcia, E., Diaz-Sastre, C., Baca, B. E. (1999) [Analytical thyroid disturbances in psychiatric inpatients.] Actas Esp. Psiquiatr. 27, 35–42.
Ataya, K., Mercado, A., Kartaginer, J., Abbasi, A., Moghissi, K. S. (1988) Bone density and reproductive hormones in patients with neuroleptic-induced hyperprolactinemia. Fertil. Steril. 50, 876–881.
Atkinson, S. A., Ward, W. E. (2001) Clinical nutrition: 2. The role of nutrition in the prevention and treatment of adult osteoporosis. Can. Med. Assoc. J. 165, 1511–1514.
Ayuso-Mateos, J. L., Montanes, F., Lastra, I., Picazo, d.l.G., Ayuso-Gutierrez, J. L. (1997) human immunodeficiency virus infection in psychiatric patients: an unlinked anonymous study. Br. J. Psychiatry 170, 181–185.
Baastrup, P. C., Christiansen, C., Transbol, I. (1980) Calcium metabolism in schizophrenic patients on long-term neuroleptic therapy. Neuropsychobiology 6, 56–59.
Bagedahl-Strindlund, M. (1986) Mentally ill mothers and their children: an epidemiological study of antenatal care consumption, obstetric conditions, and neonatal health. Acta Psychiatr. Scand. 74, 32–40.
Baillargeon, J., Ducate, S., Pulvino, J., et al. (2003) The association of psychiatric disorders and human immunodeficiency virus infection in the correctional setting. Ann. Epidemiol. 13, 606–612.
Baldwin, J. A. (1979) Schizophrenia and physical disease. Psychol. Med. 9, 611–618.
Ballenger, J. C., Post, R. M., Sternberg, D. E., et al. (1979) Headaches after lumbar puncture and insensitivity to pain in psychiatric patients. N. Engl. J. Med. 301, 110.
Ban, T. A., Guy, W., Wilson, W. H. (1985) Neuroleptic-induced skin pigmentation in chronic hospitalized schizophrenic patients. Can. J. Psychiatry 30, 406–408.
Barak, Y., Achiron, A., Mandel, M., Mirecki, I., Aizenberg, D. (2005) Reduced cancer incidence among patients with schizophrenia. Cancer 104, 2817–2821.
Basu, R., Brar, J. S., Chengappa, K. N., et al. (2004) The prevalence of the metabolic syndrome in patients with schizoaffective disorder–bipolar subtype. Bipolar Disord. 6, 314–318.
Baxter, D., Appleby, L. (1999) Case register study of suicide risk in mental disorders. Br. J. Psychiatry 175, 322–326.
Beaumont, J. G., Dimond, S. J. (1973) Brain disconnection and schizophrenia. Br. J. Psychiatry 123, 661–662.
Benca, R. M., Obermeyer, W. H., Thisted, R. A., Gillin, J. C. (1992) Sleep and psychiatric disorders: a meta-analysis. Arch. Gen. Psychiatry 49, 651–668.
Bennedsen, B. E. (1998) Adverse pregnancy outcome in schizophrenic women: occurrence and risk factors. Schizophr. Res. 33, 1–26.
Bennedsen, B. E., Mortensen, P. B., Olesen, A. V., Henriksen, T. B. (1999) Preterm birth and intra-uterine growth retardation among children of women with schizophrenia. Br. J. Psychiatry 175, 239–245.
Bennedsen, B. E., Mortensen, P. B., Olesen, A. V., Henriksen, T. B. (2001a) Congenital malformations, stillbirths, and infant deaths among children of women with schizophrenia. Arch. Gen. Psychiatry 58, 674–679.
Bennedsen, B. E., Mortensen, P. B., Olesen, A. V., Henriksen, T. B., Frydenberg, M. (2001b) Obstetric complications in women with schizophrenia. Schizophr. Res. 47, 167–175.
Bennett, N., Dodd, T., Flatley, J., Freeth, S., Bolling, K. (1995) Health Survey for England 1993. London: HMSO.
Bergemann, N., Auler, B., Parzer, P., et al. (2001) High bone turnover but normal bone mineral density in women with schizophrenia. Bone 28, 248.
Bernstein, L., Ross, R. K. (1993) Endogenous hormones and breast cancer risk. Epidemiol. Rev. 15, 48–65.
Bernstein, L., Ross, R. K., Pike, M. C., Brown, J. B., Henderson, B. E. (1990) Hormone levels in older women: a study of post-menopausal breast cancer patients and healthy population controls. Br. J. Cancer 61, 298–302.
Bilici, M., Cakirbay, H., Guler, M., et al. (2002) Classical and atypical neuroleptics, and bone mineral density, in patients with schizophrenia. Int. J. Neurosci. 112, 817–828.
Bishop, J. R., Alexander, B., Lund, B. C., Klepser, T. B. (2004) Osteoporosis screening and treatment in women with schizophrenia: a controlled study. Pharmacotherapy 24, 515–521.
Black, D. W., Winokur, G., Warrack, G. (1985) Suicide in schizophrenia: the Iowa Record Linkage Study. J. Clin. Psychiatry 46, 14–17.
Blackburn, H., Keys, A., Simonson, E., Rautaharju, P., Punsar, S. (1960) Electrocardiogram in population studies. Circulation 21, 1160–1175.
Blank, M. B., Mandell, D. S., Aiken, L., Hadley, T. R. (2002) Co-occurrence of human immunodeficiency virus and serious mental illness among Medicaid recipients. Psychiatr. Serv. 53, 868–873.
Bleuler, E. (1911) Textbook of Psychiatry. New York: Dover Publications.
Blohmke, M., Koschorrek, B., Stelzer, O. (1970) Häufigkeiten von Risikofaktoren der koronaren Herzkrankheiten in verschiedenen Altersgruppen und sozialen Schichten bei Männern. Z. Geront. 3, 201.
Blum, A., Tempey, F. W., Lynch, W. J. (1983) Somatic findings in patients with psychogenic polydipsia. J. Clin. Psychiatry 44, 55–56.
Blumensohn, R., Ringler, D., Eli, I. (2002) Pain perception in patients with schizophrenia. J. Nerv. Ment. Dis. 190, 481–483.
Bonney, W. W., Gupta, S., Hunter, D. R., Arndt, S. (1997) Bladder dysfunction in schizophrenia. Schizophr. Res. 25, 243–249.
Bowie, C. R., Harvey, P. D. (2005) Cognition in schizophrenia: impairments, determinants, and functional importance. Psychiatr. Clin. North Am. 28, 613–633, 626.
Bracken, P., Coll, P. (1985) Homocystinuria and schizophrenia: literature review and case report. J. Nerv. Ment. Dis. 173, 51–55.
Bremner, A. J., Regan, A. (1991) Intoxicated by water: polydipsia and water intoxication in a mental handicap hospital. Br. J. Psychiatry 158, 244–250.
Brookes, G., Ahmed, A. G. (2002) Pharmacological treatments for psychosis-related polydipsia. Cochrane Database Syst. Rev. CD003544.
Brown, J. S., Jr. (1996) Geographic correlation of multiple sclerosis with tick-borne diseases. Mult. Scler. 1, 257–261.
Brown, S. (1997) Excess mortality of schizophrenia: a meta-analysis. Br. J. Psychiatry 171, 502–508.
Brown, S., Birtwistle, J., Roe, L., Thompson, C. (1999) The unhealthy lifestyle of people with schizophrenia. Psychol. Med. 29, 697–701.
Brown, S., Inskip, H., Barraclough, B. (2000) Causes of the excess mortality of schizophrenia. Br. J. Psychiatry 177, 212–217.
Bundesgesundheitsministerium der BRD (1991) Daten des Gesundheitswesens. Baden-Baden: Nomos.
Burkitt, E. A., Khan, K. (1973) Myasthenia gravis and schizophrenia: a rare combination. Br. J. Psychiatry 122, 735–736.
Bushe, C., Holt, R. (2004) Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia. Br. J. Psychiatry (Suppl.) 47, S67–S71.
Cadalbert, M., Fenner, A., Schamaun, M. (1970) [Functional megacolon in mental patients.] Helv. Chir. Acta 37, 181–184.
Campbell, E. B., Foley, S. (2004) Coeliac disease and schizophrenia: data do not support hypothesis. Br. Med. J. 328, 1017.
Canuso, C. M., Goldstein, J. M., Wojcik, J., et al. (2002) Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatr. Res. 111, 11–20.
Casadebaig, F., Philippe, A., Guillaud-Bataille, J. M., et al. (1997) Schizophrenic patients: physical health and access to somatic care. Eur. Psychiatry 12, 289–293.
Casey, D. E. (1993) Neuroleptic-induced acute extrapyramidal syndromes and tardive dystinesia. Psychiatr. Clin. North Am. 16, 589–610.
Chafetz, L., White, M. C., Collins-Bride, G., Nickens, J. (2005) The poor general health of the severely mentally ill: impact of schizophrenic diagnosis. Commun. Ment. Health J. 41, 169–184.
Chaudhury, S., Chandra, S., Augustine, M. (1994) Prevalence of Australia-antigen (Hbsag) in institutionalized patients with psychosis. Br. J. Psychiatry 164, 542–543.
Chen, C. H. (1994) Seroprevalence of human immunodeficiency virus infection among Chinese psychiatric patients in Taiwan. Acta Psychiatr. Scand. 89, 441–442.
Cheng, H. S., Wang, L. C. (2005) Intestinal parasites may not cause nosocomial infections in psychiatric hospitals. Parasitol. Res. 95, 358–362.
Chong, S. A., Tan, L. L., Wong, M. C., et al. (1997) Disordered water homeostasis in Asian patients with schizophrenia. Aust. N. Z. J. Psychiatry 31, 869–873.
Chong, S. A., Mythily, Lum, A., Goh, H. Y., Chan, Y. H. (2003) Prolonged QTc intervals in medicated patients with schizophrenia. Hum. Psychopharmacol. 18, 647–649.
Chopra, I. J., Solomon, D. H., Huang, T. S. (1990) Serum thyrotropin in hospitalized psychiatric patients: evidence for hyperthyrotropinemia as measured by an ultrasensitive thyrotropin assay. Metabolism 39, 538–543.
Cividini, A., Pistorio, A., Regazzetti, A., et al. (1997) Hepatitis C virus infection among institutionalized psychiatric patients: a regression analysis of indicators of risk. J. Hepatol. 27, 455–463.
Clarke, D. J., Buckley, M. E. (1989) Familial association of albinism and schizophrenia. Br. J. Psychiatry 155, 551–553.
Clevenger, C. V., Furth, P. A., Hankinson, S. E., Schuler, L. A. (2003) The role of prolactin in mammary carcinoma. Endocr. Rev. 24, 1–27.
Cnattingius, S., Mills, J. L., Yuen, J., Eriksson, O., Salonen, H. (1997) The paradoxical effect of smoking in preeclamptic pregnancies: smoking reduces the incidence but increases the rates of perinatal mortality, abruptio placentae, and intrauterine growth restriction. Am. J. Obstet. Gynecol. 177, 156–161.
Coghlan, R., Lawrence, D., Holman, D'A., Jablensky, A. (2001) Duty to Care: Physical Illness in People with Mental Illness. Perth, WA: University of Western Australia, Department of Public Health, Department of Psychiatry and Behavioural Science. Available online at www.populationhealth.uwa.edu.au/dutytocare
Cohen, A. J., Roe, F. J. (2000) Review of risk factors for osteoporosis with particular reference to a possible aetiological role of dietary salt. Food Chem. Toxicol. 38, 237–253.
Cohen, D., Gispen-de Wied, C. C. (2003) [Schizophrenia and diabetes mellitus: not an improbable combination.] Ned. Tijdschr. Geneeskd. 147, 993–996.
Cohen, H., Loewenthal, U., Matar, M., Kotler, M. (2001) [Heart rate variability in schizophrenic patients treated with antipsychotic agents.] Harefuah 140, 1142–7, 1231.
Cohen, K. L., Swigar, M. E. (1979) Thyroid function screening in psychiatric patients. J. Am. Med. Ass. 242, 254–257.
Cohen, M., Dembling, B., Schorling, J. (2002) The association between schizophrenia and cancer: a population-based mortality study. Schizophr. Res. 57, 139–146.
Cohler, B. J., Gallant, D. H., Grunebaum, H. U., Weiss, J. L., Gamer, E. (1975) Pregnancy and birth complications among mentally ill and well mothers and their children. Soc. Biol. 22, 269–278.
Cohn, T., Prud'homme, D., Streiner, D., Kameh, H., Remington, G. (2004) Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome. Can. J. Psychiatry 49, 753–760.
Colton, C. W., Manderscheid, R. W. (2006) Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev. Chronic Dis. 3, A42.
Conejero-Goldberg, C., Torrey, E. F., Yolken, R. H. (2003) Herpesviruses and Toxoplasma gondii in orbital frontal cortex of psychiatric patients. Schizophr. Res. 60, 65–69.
Coodin, S. (2001) Body mass index in persons with schizophrenia. Can. J. Psychiatry 46, 549–555.
Cooper, A. F. (1976) Deafness and psychiatric illness. Br. J. Psychiatry 129, 216–226.
Correll, C. U., Leucht, S., Kane, J. M. (2004) Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am. J. Psychiatry 161, 414–425.
Cotran, R. S., Kumar, V., Robbins, S. L. (1989) Robbins Pathologic Basis of Disease, 4th edn. Philadelphia, PA: W.B. Saunders.
Council of the National Osteoporosis Foundation (1996) Guidelines for the early detection of osteoporosis and prediction of fracture risk. S. Afr. Med. J. 86, 1113–1116.
Cournos, F., McKinnon, K. (1997) human immunodeficiency virus seroprevalence among people with severe mental illness in the United States: a critical review. Clin. Psychol. Rev. 17, 259–269.
Cournos, F., Empfield, M., Horwath, E., et al. (1991) human immunodeficiency virus seroprevalence among patients admitted to two psychiatric hospitals. Am. J. Psychiatry 148, 1225–1230.
Cournos, F., Horwath, E., Guido, J. R., McKinnon, K., Hopkins, N. (1994) human immunodeficiency virus-1 infection at two public psychiatric hospitals in New York City. acquired immundeficiency syndrome Care 6, 443–452.
Cradock-O'Leary, J., Young, A. S., Yano, E. M., Wang, M. M., Lee, M. L. (2002) Use of general medical services by ventricular arrhythmia patients with psychiatric disorders. Psychiatr. Serv. 53, 874–878.
Cramer, J. A., Rosenheck, R. (1998) Compliance with medication regimens for mental and physical disorders. Psychiatr. Serv. 49, 196–201.
Creese, I., Feinberg, A. P., Snyder, S. H. (1976) Butyrophenone influences on the opiate receptor. Eur. J. Pharmacol. 36, 231–235.
Curkendall, S. M., Mo, J., Glasser, D. B., Rose, S. M., Jones, J. K. (2004) Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada. J. Clin. Psychiatry 65, 715–720.
Dalton, S. O., Munk, L. T., Mellemkjaer, L., Johansen, C., Mortensen, P. B. (2003) Schizophrenia and the risk for breast cancer. Schizophr. Res. 62, 89–92.
Dalton, S. O., Laursen, T. M., Mellemkjaer, L., Johansen, C., Mortensen, P. B. (2004) Risk for cancer in parents of patients with schizophrenia. Am. J. Psychiatry 161, 903–908.
Dalton, S. O., Mellemkjaer, L., Thomassen, L., Mortensen, P. B., Johansen, C. (2005) Risk for cancer in a cohort of patients hospitalized for schizophrenia in Denmark, 1969–1993. Schizophr. Res. 75, 315–324.
Dasananjali, T. (1994) The prevalence of human immunodeficiency virus infection among mentally ill offenders in Thailand. J. Med. Assoc. Thai. 77, 257–260.
Daumit, G. L., Goldberg, R. W., Anthony, C., et al. (2005) Physical activity patterns in adults with severe mental illness. J. Nerv. Ment. Dis. 193, 641–646.
Daumit, G. L., Pronovost, P. J., Anthony, C. B., et al. (2006) Adverse events during medical and surgical hospitalizations for persons with schizophrenia. Arch. Gen. Psychiatry 63, 267–272.
David, A., Malmberg, A., Lewis, G., Brandt, L., Allebeck, P. (1995) Are there neurological and sensory risk factors for schizophrenia? Schizophr. Res. 14, 247–251.
Davidson, M. (2002) Risk of cardiovascular disease and sudden death in schizophrenia. J. Clin. Psychiatry 63 (Suppl. 9), 5–11.
Davidson, S., Judd, F., Jolley, D., et al. (2001) Cardiovascular risk factors for people with mental illness. Aust. N. Z. J. Psychiatry 35, 196–202.
Davis, G. C., Buchsbaum, M. S., Naber, D., et al. (1982) Altered pain perception and cerebrospinal endorphins in psychiatric illness. Ann. N. Y. Acad. Sci. 398, 366–373.
Davis, J. M., Cole, J. O. (1975) Antipsychotic drugs. In American Handbook of Psychiatry, ed. S. Arieti. New York: Basic Books, pp. 441–475.
De Hert, M. A., van Winkel, R., Van Eyck, D., et al. (2006) Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. Schizophr. Res. 83, 87–93.
de Leon, J. (2003) Polydipsia: a study in a long-term psychiatric unit. Eur. Arch. Psychiatr Clin. Neurosci. 253, 37–39.
de Leon, J., Diaz, F. J. (2005) A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr. Res. 76, 135–157.
de Leon, J., Verghese, C., Tracy, J. I., Josiassen, R. C., Simpson, G. M. (1994) Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature. Biol. Psychiatry 35, 408–419.
de Leon, J., Dadvand, M., Canuso, C., et al. (1996) Polydipsia and water intoxication in a long-term psychiatric hospital. Biol. Psychiatry 40, 28–34.
de Leon, J., Tracy, J., McCann, E., McGrory, A. (2002) Polydipsia and schizophrenia in a psychiatric hospital: a replication study. Schizophr. Res. 57, 293–301.
De Santis, A., Addolorato, G., Romito, A., et al. (1997) Schizophrenic symptoms and SPECT abnormalities in a coeliac patient: regression after a gluten-free diet. J. Intern. Med. 242, 421–423.
Delaplaine, R., Ifabumuyi, O. I., Merskey, H., Zarfas, J. (1978) Significance of pain in psychiatric hospital patients. Pain 4, 361–366.
Delisi, L. E., Smith, S. B., Hamovit, J. R., et al. (1986) Herpes simplex virus, cytomegalovirus and Epstein–Barr virus antibody titres in sera from schizophrenic patients. Psychol. Med. 16, 757–763.
Delva, N. J., Crammer, J. L., Jarzylo, S. V., et al. (1989) Osteopenia, pathological fractures, and increased urinary calcium excretion in schizophrenic patients with polydipsia. Biol. Psychiatry 26, 781–793.
Desai, M. M., Rosenheck, R. A., Druss, B. G., Perlin, J. B. (2002) Mental disorders and quality of diabetes care in the veterans health administration. American Journal of Psychiatry 159, 1584–1590.
Destounis, N. (1966) The relationship between schizophrenia and toxoplasmosis: a critical study. Del. Med. J. 38, 349–351.
Dewan, M. J., Bick, P. A. (1985) Normal pressure hydrocephalus and psychiatric patients. Biol. Psychiatry 20, 1127–1131.
Dickerson, F. B., Brown, C. H., Kreyenbuhl, J., et al. (2004) Sexual and reproductive behaviors among persons with mental illness. Psychiatr. Serv. 55, 1299–1301.
Dickerson, F. B., Brown, C. H., Daumit, G. L., et al. (2006) Health status of individuals with serious mental illness. Schizophr. Bull. 32, 584–589.
Dickerson, J. W., Wiryanti, J. (1978) Pellagra and mental disturbance. Proc. Nutr. Soc. 37, 167–171.
Dickson, R. A., Glazer, W. M. (1999) Neuroleptic-induced hyperprolactinemia. Schizophr. Res. 35 (Suppl.), S75–S86.
Dixon, L., Haas, G., Weiden, P. J., Sweeney, J., Frances, A. J. (1991) Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am. J. Psychiatry 148, 224–230.
Dixon, L., Postrado, L., Delahanty, J., Fischer, P. J., Lehman, A. (1999) The association of medical comorbidity in schizophrenia with poor physical and mental health. J. Nerv. Ment. Dis. 187, 496–502.
Dixon, L., Weiden, P., Delahanty, J., et al. (2003) Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr. Bull. 26, 903–912.
Dohan, F. C., Grasberger, J. C. (1973) Relapsed schizophrenics: earlier discharge from the hospital after cereal-free, milk-free diet. Am. J. Psychiatry 130, 685–688.
Dohan, F. C., Grasberger, J. C., Lowell, F. M., Johnston, H. T., Jr., Arbegast, A. W. (1969) Relapsed schizophrenics: more rapid improvement on a milk- and cereal-free diet. Br. J. Psychiatry 115, 595–596.
Dorrell, W. (1973) Myasthenia gravis and schizophrenia. Br. J. Psychiatry 123, 249.
Drake, R. E., Wallach, M. A. (1989) Substance abuse among the chronic mentally ill. Hosp. Commun. Psychiatry 40, 1041–1046.
Drake, R. E., Rosenberg, S. D., Mueser, K. T. (1996) Assessing substance use disorder in persons with severe mental illness. New Dir. Ment. Health Serv. 70, 3–17.
Drossman, D. A. (1994) Irritable bowel syndrome. Gastroenterologist 2, 315–326.
Duc, L. (1952) [Contribution to the study of the disorders of carbohydrate metabolism in mental disorders: diabetes and psychoses.] Schweiz. Arch. Neurol. Psychiatr. 69, 89–169.
du Pan, R. M., Muller, C. (1977) [Cancer mortality in patients of psychiatric hospitals.] Schweiz. Med. Wochenschr. 107, 597–604.
Dupont, A., Jensen, O. M., Strömgren, E., Jablensky, A. (1986) Incidence of cancer in patients diagnosed as schizophrenic in Denmark. In Psychiatric Case Registers in Public Health, eds. G. H. Ten Horn, R. Giel, W. H. Gulbinat. Amsterdam: Elsevier, pp. 229–239.
Dworkin, R. H. (1994) Pain insensitivity in schizophrenia: a neglected phenomenon and some implications. Schizophr. Bull. 20, 235–248.
Eaton, W. W., Hayward, C., Ram, R. (1992) Schizophrenia and rheumatoid arthritis: a review. Schizophr. Res. 6, 181–192.
Eaton, W. W., Mortensen, P. B., Agerbo, E., et al. (2004) Coeliac disease and schizophrenia: population-based case control study with linkage of Danish national registers. Br. Med. J. 328, 438–439.
Eaton, W. W., Byrne, M., Ewald, H., et al. (2006) Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am. J. Psychiatry 163, 521–528.
Ebert, T., Kotler, M. (2005) Prenatal exposure to influenza and the risk of subsequent development of schizophrenia. Isr. Med. Assoc. J. 7, 35–38.
Ehrentheil, O. F. (1957) Common medical disorders rarely found in psychotic patients. Am. Med. Assoc. Arch. Neurol. Psychiatry 77, 178–186.
Empfield, M., Cournos, F., Meyer, I., et al. (1993) human immunodeficiency virus seroprevalence among homeless patients admitted to a psychiatric inpatient unit. Am. J. Psychiatry 150, 47–52.
Emsley, R. A., van der Meer, M. H., Aalbers, C., Taljaard, J. J. (1990) Inappropriate antidiuretic state in long-term psychiatric inpatients. S. Afr. Med. J. 77, 307–308.
Enger, C., Weatherby, L., Reynolds, R. F., Glasser, D. B., Walker, A. M. (2004) Serious cardiovascular events and mortality among patients with schizophrenia. J. Nerv. Ment. Dis. 192, 19–27.
Erlenmeyer-Kimling, L. (1968) Mortality rates in the offspring of schizophrenic parents and a physiological advantage hypothesis. Nature 220, 798–800.
Essen-Moller, W. (1935) Untersuchungen über die Fruchtbarkeit gewisser Gruppen von Geisteskranken. Acta Psychiatr. Neurol. (Suppl.) 8, 1–314.
Evenson, R. C., Jos, C. J., Mallya, A. R. (1987) Prevalence of polydipsia among public psychiatric patients. Psychol. Rep. 60, 803–807.
Ewald, H., Mortensen, P. B., Mors, O. (2001) Decreased risk of acute appendicitis in patients with schizophrenia or manic-depressive psychosis. Schizophr. Res. 49, 287–293.
Expert Group: Schizophrenia and Diabetes 2003 (2004) Expert Consensus Meeting, Dublin, 3–4 October 2003: consensus summary. Br. J. Psychiatry (Suppl.) 47, S112-S114.
Fellerhoff, B., Laumbacher, B., Wank, R. (2005) High risk of schizophrenia and other mental disorders associated with chlamydial infections: hypothesis to combine drug treatment and adoptive immunotherapy. Med. Hypotheses 65, 243–252.
Fenton, W. S. (2000) Prevalence of spontaneous dyskinesia in schizophrenia. J. Clin. Psychiatry 61, 10–14.
Ferrier, I. N. (1985) Water intoxication in patients with psychiatric illness. Br. Med. J. (Clin. Res. Edn) 291, 1594–1596.
Filik, R., Sipos, A., Kehoe, P. G., et al. (2006) The cardiovascular and respiratory health of people with schizophrenia. Acta Psychiatr. Scand. 113, 298–305.
Fisher, I. I., Bienskii, A. V., Fedorova, I. V. (1996) Experience in using serological tests in detecting tuberculosis in patients with severe mental pathology. Probl. Tuberk. 1, 19–20.
Folsom, D. P., McCahill, M., Bartels, S., et al. (2002) Medical comorbidity and receipt of medical care by older homeless people with schizophrenia or depression. Psychiatri. Serv. 53, 1456–1460.
Fox, B. H., Howell, M. A. (1974) Cancer risk among psychiatric patients: a hypothesis. Int. J. Epidemiol. 3, 207–208.
Freedman, R. (2003) Schizophrenia. N. Engl. J. Med. 349, 1738–1749.
Friedlander, A. H., Marder, S. R. (2002) The psychopathology, medical management and dental implications of schizophrenia. J. Am. Dent. Assoc. 133, 603–610.
Galbraith, D. A., Gordon, B. A., Feleki, V., Gordon, N., Cooper, A. J. (1989) Metachromatic leukodystrophy (metachromatic leukodystrophy) in hospitalized adult schizophrenic patients resistant to drug treatment. Can. J. Psychiatry 34, 299–302.
Gallien, M., Schnetzler, J. P., Morin, J. (1975) [Antinuclear antibodies and lupus due to phenothiazines in 600 hospitalized patients.] Ann. Med. Psychol. (Paris) 1, 237–248.
Geschwind, N. (1977) Insensitivity to pain in psychotic patients. N. Engl. J. Med. 296, 1480.
Ghadirian, A. M., Chouinard, G., Annable, L. (1982) Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients. J. Nerv. Ment. Dis. 170, 463–467.
Gingell, K. H., Darley, J. S., Lengua, C. A., Baddela, P. (1993) Menstrual changes with antipsychotic drugs. Br. J. Psychiatry 162, 127.
Gittleson, N. L., Richardson, T. D. (1973) Myasthenia gravis and schizophrenia: a rare combination. Br. J. Psychiatry 122, 343–344.
Goff, D. C., Sullivan, L. M., McEvoy, J. P., et al. (2005) A comparison of ten-year cardiac risk estimates in schizophrenia patients from the Clinical Trials of Antipsychotic Treatment Effectiveness study and matched controls. Schizophr. Res. 80, 45–53.
Goffin, V., Touraine, P., Pichard, C., Bernichtein, S., Kelly, P. A. (1999) Should prolactin be reconsidered as a therapeutic target in human breast cancer? Mol. Cell. Endocrinol. 151, 79–87.
Goldacre, M. J., Kurina, L. M., Yeates, D., Seagroat, V., Gill, L. (2000) Use of large medical databases to study associations between diseases. Q. J. Med. 93, 669–675.
Goldacre, M. J., Kurina, L. M., Wotton, C. J., Yeates, D., Seagroat, V. (2005) Schizophrenia and cancer: an epidemiological study. Br. J. Psychiatry 187, 334–338.
Goldfarb, W. (1958) Pain reactions in a group of institutionalized schizophrenic children. Am. J. Orthopsychiatry 28, 777–785.
Goldman, L. S. (1999) Medical illness in patients with schizophrenia. J. Clin. Psychiatry 60 (Suppl. 21), 10–15.
Goodman, S. H., Emory, E. K. (1992) Perinatal complications in births to low socioeconomic status schizophrenic and depressed women. J. Abnorm. Psychol. 101, 225–229.
Gottesman, I. I., Groome, C. S. (1997) human immunodeficiency virus/acquired immundeficiency syndrome risks as a consequence of schizophrenia. Schizophr. Bull. 23, 675–684.
Gourdy, P., Ruidavets, J. B., Ferrieres, J., et al. (2001) Prevalence of type 2 diabetes and impaired fasting glucose in the middle-aged population of three French regions: the MONICA study 1995–97. Diabetes Metab. 27, 347–358.
Grady, D., Rubin, S. M., Petitti, D. B., et al. (1992) Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med. 117, 1016–1037.
Grassi, L. (1996) Risk of human immunodeficiency virus infection in psychiatrically ill patients. acquired immundeficiency syndrome Care 8, 103–116.
Gregg, D. (1939) The paucity of arthritis among psychotic cases. Am. J. Psychiatry 95, 853–858.
Grinshpoon, A., Barchana, M., Ponizovsky, A., et al. (2005) Cancer in schizophrenia: is the risk higher or lower? Schizophr. Res. 73, 333–341.
Gulbinat, W., Dupont, A., Jablensky, A., et al. (1992) Cancer incidence of schizophrenic patients: results of record linkage studies in three countries. Br. J. Psychiatry (Suppl.) 18, 75–83.
Gupta, S., Masand, P. S., Kaplan, D., Bhandary, A., Hendricks, S. (1997) The relationship between schizophrenia and irritable bowel syndrome (irritable bowel syndrome). Schizophr. Res. 23, 265–268.
Hafner, H., Maurer, K., Loffler, W., et al. (1994) The epidemiology of early schizophrenia: influence of age and gender on onset and early course. Br. J. Psychiatry (Suppl.) 23, 29–38.
Halbreich, U., Palter, S. (1996) Accelerated osteoporosis in psychiatric patients: possible pathophysiological processes. Schizophr. Bull. 22, 447–454.
Halbreich, U., Rojansky, N., Palter, S., et al. (1995) Decreased bone mineral density in medicated psychiatric patients. Psychosom. Med. 57, 485–491.
Halbreich, U., Kinon, B. J., Gilmore, J. A., Kahn, L. S. (2003) Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects. Psychoneuroendocrinology 28 (Suppl. 1), 53–67.
Halonen, P. E., Rimon, R., Arohonka, K., Jantti, V. (1974) Antibody levels to herpes simplex type I, measles and rubella viruses in psychiatric patients. Br. J. Psychiatry 125, 461–465.
Harris, E. C., Barraclough, B. (1998) Excess mortality of mental disorder. Br. J. Psychiatry 173, 11–53.
Harrison, G., Owens, D., Holton, A., Neilson, D., Boot, D. (1988) A prospective study of severe mental disorder in Afro-Caribbean patients. Psychol. Med. 18, 643–657.
Harvey, I., Williams, M., McGuffin, P., Toone, B. K. (1990) The functional psychoses in Afro-Caribbeans. Br. J. Psychiatry 157, 515–522.
Hatta, K., Takahashi, T., Nakamura, H., et al. (1998) Abnormal physiological conditions in acute schizophrenic patients on emergency admission: dehydration, hypokalemia, leukocytosis and elevated serum muscle enzymes. Eur. Arch. Psychiatr. Clin. Neurosci. 248, 180–188.
Heiskanen, T., Niskanen, L., Lyytikainen, R., Saarinen, P. I., Hintikka, J. (2003) Metabolic syndrome in patients with schizophrenia. J. Clin. Psychiatry 64, 575–579.
Hennessy, S., Bilker, W. B., Knauss, J. S., et al. (2002) Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. Br. Med. J. 325, 1070.
Herkert, E. E., Wald, A., Romero, O. (1972) Tuberous sclerosis and schizophrenia. Dis. Nerv. Syst. 33, 439–445.
Herold, G. (2002) Innere Medizin. Köln: Gerd Herold.
Hinterhuber, H., Lochenegg, L. (1975) [Gastric ulcers, stress and schizophrenia: incidence of gastric ulcers in male schizophrenic patients.] Arch. Psychiatr. Nervenkr. 220, 335–345.
Hoffer, A. (1970) Pellagra and schizophrenia. Psychosomatics 11, 522–525.
Holt, R. I., Peveler, R. C., Byrne, C. D. (2004) Schizophrenia, the metabolic syndrome and diabetes. Diabet. Med. 21, 515–523.
Homel, P., Casey, D., Allison, D. B. (2002) Changes in body mass index for individuals with and without schizophrenia, 1987–1996. Schizophr. Res. 55, 277–284.
Horrobin, D. F., Ally, A. I., Karmali, R. A., et al. (1978) Prostaglandins and schizophrenia: further discussion of the evidence. Psychol. Med. 8, 43–48.
Hoskins, R. G., Sleeper F. H. (1933) Organic functions in schizophrenia. Arch. Neurol. Psychiat. 30, 123–140.
Howard, L., Shah, N., Salmon, M., Appleby, L. (2003) Predictors of social services supervision of babies of mothers with mental illness after admission to a psychiatric mother and baby unit. Soc. Psychiatry Psychiatr. Epidemiol. 38, 450–455.
Howland, R. H. (1990) Schizophrenia and amyotrophic lateral sclerosis. Compr. Psychiatry 31, 327–336.
Hsiao, C. C., Ree, S. C., Chiang, Y. L., Yeh, S. S., Chen, C. K. (2004) Obesity in schizophrenic outpatients receiving antipsychotics in Taiwan. Psychiatry Clin. Neurosci. 58, 403–409.
Hummer, M., Malik, P., Gasser, R. W., et al. (2005) Osteoporosis in patients with schizophrenia. Am. J. Psychiatry 162, 162–167.
Hung, C. F., Wu, C. K., Lin, P. Y. (2005) Diabetes mellitus in patients with schizophrenia in Taiwan. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 523–527.
Hunt, C. E., Shannon, D. C. (1992) Sudden infant death syndrome and sleeping position. Pediatrics 90, 115–118.
Hussar, A. E. (1965) Coronary heart disease in chronic schizophrenic patients: a clinicopathologic study. Circulation 31, 919–929.
Hussar, A. E. (1968) Peptic ulcer in long-term institutionalized schizophrenic patients. Psychosom. Med. 30, 374–377.
Ingram, D. M., Nottage, E. M., Roberts, A. N. (1990) Prolactin and breast cancer risk. Med. J. Aust. 153, 469–473.
Inoue, H., Hazama, H., Ogura, C., Ichikawa, M., Tamura, T. (1980) Neuroendocrinological study of amenorrhea induced by antipsychotic drugs. Folia Psychiatr. Neurol. Jap. 34, 181.
Jablensky, A. V., Morgan, V., Zubrick, S. R., Bower, C., Yellachich, L. A. (2005) Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am. J. Psychiatry 162, 79–91.
Jakubaschk, J., Boker, W. (1991) [Disorders of pain perception in schizophrenia.] Schweiz. Arch. Neurol. Psychiatr. 142, 55–76.
Jara-Prado, A., Yescas, P., Sanchez, F. J., et al. (2000) Prevalence of acute intermittent porphyria in a Mexican psychiatric population. Arch. Med. Res. 31, 404–408.
Jeste, D. V., Gladsjo, J. A., Lindamer, L. A., Lacro, J. P. (1996) Medical comorbidity in schizophrenia. Schizophr. Bull. 22, 413–430.
Jeste, S. D., Patterson, T. L., Palmer, B. W., et al. (2003) Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schizophr. Res. 63, 49–58.
Jones, G. R. (1985) Cancer therapy: phenothiazines in an unexpected role. Tumori 71, 563–569.
Jones, L. E., Clarke, W., Carney, C. P. (2004) Receipt of diabetes services by insured adults with and without claims for mental disorders. Med. Care 42, 1167–1175.
Jose, C. J., Perez-Cruet, J. (1979) Incidence and morbidity of self-induced water intoxication in state mental hospital patients. Am. J. Psychiatry 136, 221–222.
Kaelbling, R., Craig, J. B., Pasamanick, B. (1961) Urinary porphobilinogen: results of screening 2500 psychiatric patients. Arch. Gen. Psychiatry 5, 494–508.
Kales, A., Marusak, C. (1967) Sleep patterns associated with neurological and psychiatric disorders. Bull. Los Angeles Neurol. Soc. 32, 234–242.
Kalkan, A., Ozdarendeli, A., Bulut, Y., et al. (2005) Prevalence and genotypic distribution of hepatitis GB-C/HG and TT viruses in blood donors, mentally retarded children and four groups of patients in eastern Anatolia, Turkey. Jpn. J. Infect. Dis. 58, 222–227.
Kaplan, H. S., Sager, C. J., Schwartz, S., Kaye, A., Glass, G. B. (1970) Post-gastrectomy pain and schizophrenia. Psychosomatics 11, 157–163.
Keely, E. J., Reiss, J. P., Drinkwater, D. T., Faiman, C. (1997) Bone mineral density, sex hormones, and long-term use of neuroleptic agents in men. Endocrinol. Pract. 3, 209–213.
Kelly, C., McCreadie, R. G. (1999) Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. Am. J. Psychiatry 156, 1751–1757.
Kenkre, A. M., Spadigam, A. E. (2000) Oral health and treatment needs in institutionalized psychiatric inpatients in India. Indian J. Dent. Res. 11, 5–11.
King, D. L., Cooper, S. J., Earle, J. A., et al. (1985) A survey of serum antibodies to eight common viruses in psychiatric patients. Br. J. Psychiatry 147, 137–144.
Kirch, D. G., Bigelow, L. B., Weinberger, D. R., Lawson, W. B., Wyatt, R. J. (1985) Polydipsia and chronic hyponatremia in schizophrenic inpatients. J. Clin. Psychiatry 46, 179–181.
Kishimoto, T., Watanabe, K., Takeuchi, H., et al. (2005) Bone mineral density measurement in female inpatients with schizophrenia. Schizophr. Res. 77, 113–115.
Kleinberg, D. L., Davis, J. M., de Coster, R., Van Baelen, B., Brecher, M. (1999) Prolactin levels and adverse events in patients treated with risperidone. J. Clin. Psychopharmacol. 19, 57–61.
Klibanski, A., Neer, R. M., Beitins, I. Z., et al. (1980) Decreased bone density in hyperprolactinemic women. N. Engl. J. Med. 303, 1511–1514.
Kooy, F. H. (1919) Hyperglycemia in mental disorders. Brain 42, 214–288.
Korhonen, S., Hippelainen, M., Niskanen, L., Vanhala, M., Saarikoski, S. (2001) Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study. Am. J. Obstet. Gynecol. 184, 289–296.
Krakowski, A. J., Rydzynski, A., Jarosz, M., Engelsmann, F. (1983) Prevalence of psychosomatic disorders in schizophrenic patients in Poland. In Psychosomatic Medicine: Theoretical, Clinical and Transcultural Aspects, eds. A. J. Krakowski, R. Kimbal. New York: Plenum Press, 69–78.
Kroll, J. (2001) Schizophrenia and liver dysfunction. Med. Hypotheses 56, 634–636.
Kunugi, H., Nanko, S., Murray, R. M. (2001) Obstetric complications and schizophrenia: prenatal underdevelopment and subsequent neurodevelopmental impairment. Br. J. Psychiatry (Suppl.) 40, S25–S29.
Laaksonen, D. E., Lakka, H. M., Niskanen, L. K., et al. (2002) Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am. J. Epidemiol. 156, 1070–1077.
Lambert, M. T., Bjarnason, I., Connelly, J., et al. (1989) Small intestine permeability in schizophrenia. Br. J. Psychiatry 155, 619–622.
Lane, E. A., Albee, G. W. (1970) The birth weight of children born to schizophrenic women. J. Psychol. 74, 157–160.
Lauerma, H., Lehtinen, V., Joukamaa, M., et al. (1998) Schizophrenia among patients treated for rheumatoid arthritis and appendicitis. Schizophr. Res. 29, 255–261.
Lautenbacher, S., Krieg, J. C. (1994) Pain perception in psychiatric disorders: a review of the literature. J. Psychiatr. Res. 28, 109–122.
Lawrence, D. M., Holman, C. D., Jablensky, A. V., Threlfall, T. J., Fuller, S. A. (2000) Excess cancer mortality in Western Australian psychiatric patients due to higher case fatality rates. Acta Psychiatr. Scand. 101, 382–388.
Lawrence, D. M., Jablensky, A. V., Holman, C. D. J. (2001) Duty to Care: Physical Illness in People with Mental Illness. Available online at http://cdh.curtin.edu.au/publications/2001.cfm/
Lawrence, D. M., Holman, C. D., Jablensky, A. V., Hobbs, M. S. (2003) Death rate from ischaemic heart disease in Western Australian psychiatric patients 1980–1998. Br. J. Psychiatry 182, 31–36.
Lee, H. K., Travin, S., Bluestone, H. (1992) human immunodeficiency virus-1 in inpatients. Hosp. Commun. Psychiatry 43, 181–182.
Leucht, S. M., Pitschel-Walz, G., Abraham, D., Kissling, W. (1999) Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo: a meta-analysis or randomized controlled trials. Schizophr. Res. 35, 51–68.
Levine, J., Agam, G., Sela, B. A., et al. (2005a) cerebrospinal fluid homocysteine is not elevated in schizophrenia. J. Neur. Transm. 112, 297–302.
Levine, J., Sela, B. A., Osher, Y., Belmaker, R. H. (2005b) High homocysteine serum levels in young male schizophrenia and bipolar patients and in an animal model. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 1181–1191.
Levy, D. L., Holzman, P. S., Proctor, L. R. (1983) Vestibular dysfunction and psychopathology. Schizophr. Bull. 9, 383–438.
Levy, R. P., Jensen, J. B., Laus, V. G., Agle, D. P., Engel, I. M. (1981) Serum thyroid hormone abnormalities in psychiatric disease. Metabolism 30, 1060–1064.
Lewis, S., Jagger, R. G., Treasure, E. (2001) The oral health of psychiatric in-patients in South Wales. Spec. Care Dentist. 21, 182–186.
Lichtermann, D., Ekelund, J., Pukkala, E., Tanskanen, A., Lonnqvist, J. (2001) Incidence of cancer among persons with schizophrenia and their relatives. Arch. Gen. Psychiatry 58, 573–578.
Lieberman, A. L. (1955) Painless myocardial infarction in psychotic patients. Geriatrics 10, 579–580.
Lin, C. C., Bai, Y. M., Chen, J. Y., Lin, C. Y., Lan, T. H. (1999) A retrospective study of clozapine and urinary incontinence in Chinese in-patients. Acta Psychiatr. Scand. 100, 158–161.
Liu-Seifert, H., Kinon, B. J., Ahl, J., Lamberson, S. (2004) Osteopenia associated with increased prolactin and aging in psychiatric patients treated with prolactin-elevating antipsychotics. Ann. N. Y. Acad. Sci. 1032, 297–298.
Llovera, M., Pichard, C., Bernichtein, S., et al. (2000) Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation. Oncogene 19, 4695–4705.
Lovett Doust, J. W. (1980) Sinus tachycardia and abnormal cardiac rate variation in schizophrenia. Neuropsychobiology 6, 305–312.
Lycke, E., Norrby, R., Roos, B. E. (1974) A serological study on mentally ill patients with particular reference to the prevalence of herpes virus infections. Br. J. Psychiatry 124, 273–279.
Macdonald, S., Halliday, J., MacEwan, T., et al. (2003) Nithsdale Schizophrenia Surveys 24: sexual dysfunction – case-control study. Br. J. Psychiatry 182, 50–56.
Magharious, W., Goff, D. C., Amico, E. (1998) Relationship of gender and menstrual status to symptoms and medication side effects in patients with schizophrenia. Psychiatr. Res. 77, 159–166.
Marchand Walter, E. (1955) Occurrence of painless myocardial infarction in psychotic patients. N. Engl. J. Med. 253, 51–55.
Marchand Walter, E., Sarota, B., Marble, H. C., et al. (1959) Occurrence of painless acute surgical disorders in psychotic patients. N. Engl. J. Med. 260, 580–585.
Marcus, J., Auerbach, J., Wilkinson, L., Burack, C. M. (1981) Infants at risk for schizophrenia: the Jerusalem Infant Development Study. Arch. Gen. Psychiatry 38, 703–713.
Marder, S. R., Essock, S. M., Miller, A. L., et al. (2004) Physical health monitoring of patients with schizophrenia. Am. J. Psychiatry 161, 1334–1349.
Martinez-Bermejo, A., Polanco, I. (2002) [Neuropsychological changes in coeliac disease.] Rev. Neurol. 34 (Suppl. 1), S24–S33.
Mason, P. R., Winton, F. E. (1995) Ear disease and schizophrenia: a case-control study. Acta Psychiatr. Scand. 91, 217–221.
Masterson, E., O'Shea, B. (1984) Smoking and malignancy in schizophrenia. Br. J. Psychiatry 145, 429–432.
Maudsley, H. (1979) The Pathology of Mind, 3rd end. London: Macmillan.
May, P. R. A. (1948) Pupillary abnormalities in schizophrenia and during muscular effort. J. Ment. Sci. 94, 89–98.
McCreadie, R. G. (2003) Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br. J. Psychiatry 183, 534–539.
McCreadie, R. G., Stevens, H., Henderson, J., et al. (2004) The dental health of people with schizophrenia. Acta Psychiatr. Scand. 110, 306–310.
McDermott, S., Moran, R., Platt, T., et al. (2005) Heart disease, schizophrenia, and affective psychoses: epidemiology of risk in primary care. Commun. Ment. Health J. 41, 747–755.
McEvoy, J. P., Meyer, J. M., Goff, D. C., et al. (2005) Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (Clinical Trials of Antipsychotic Treatment Effectiveness) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr. Res. 80, 19–32.
McGuffin, P., Gardiner, P., Swinburne, L. M. (1981) Schizophrenia, celiac disease, and antibodies to food. Biol. Psychiatry 16, 281–285.
McKee, H. A., D'Arcy, P. F., Wilson, P. J. (1986) Diabetes and schizophrenia: a preliminary study. J. Clin. Hosp. Pharm. 11, 297–299.
McLarty, D. G., Ratcliffe, W. A., Ratcliffe, J. G., Shimmins, J. G., Goldberg, A. (1978) A study of thyroid function in psychiatric in-patients. Br. J. Psychiatry 133, 211–218.
McNeil, T. F., Kaij, L. (1973) Obstetric complications and physical size of offspring of schizophrenic, schizophrenic-like, and control mothers. Br. J. Psychiatry 123, 341–348.
McNeil, T. F., Kaij, L., Malmquist-Larsson, A., et al. (1983) Offspring of women with nonorganic psychoses: development of a longitudinal study of children at high risk. Acta Psychiatr. Scand. 68, 234–250.
Meaney, A. M., O'Keane, V. (2002) Prolactin and schizophrenia: clinical consequences of hyperprolactinaemia. Life Sci. 71, 979–992.
Meaney, A. M., Smith, S., Howes, O. D., et al. (2004) Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia. Br. J. Psychiatry 184, 503–508.
Mednick, S. A., Mura, E., Schulsinger, F., Mednick, B. (1971) Perinatal conditions and infant development in children with schizophrenic parents. Soc. Biol. 18, S103–S113.
Mellsop, G. W., Koadlow, L., Syme, J., Whittingham, S. (1974) Absence of rheumatoid arthritis in schizophrenia. Aust. N. Z. J. Med. 4, 247–252.
Meltzer, H. Y. (1976) Serum creatine phosphokinase in schizophrenia. Am. J. Psychiatry 133, 192–197.
Meltzer, H. Y., Davidson, M., Glassman, A. H., Vieweg, W. V. (2002) Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment. J. Clin. Psychiatry 63 (Suppl. 9), 25–29.
Mercier-Guidez, E., Loas, G. (2000) Polydipsia and water intoxication in 353 psychiatric inpatients: an epidemiological and psychopathological study. Eur. Psychiatry 15, 306–311.
Meyer, J. M. (2003) Cardiovascular illness and hyperlipidemia in patients with schizophrenia. In Medical Illness and Schizophrenia, eds. J. M. Meyer, H. A. Nasrallah. Washington, DC: American Psychiatric Publishing, pp. 53–80.
Meyer, J. M., Koro, C. E. (2004) The effects of antipsychotic therapy on serum lipids: a comprehensive review. Schizophr. Res. 70, 1–17.
Meyer, J. M., Nasrallah, H. A. (eds.) (2003) Medical illness and schizophrenia. Washington, DC: American Psychiatric Publishing.
Meyer, I., McKinnon, K., Cournos, F., et al. (1993) (human immunodeficiency virus seroprevalence among long-stay patients in a state psychiatric hospital. Hosp. Commun. Psychiatry 44, 282–284.
Meyer, J. M., Koro, C. E., L'Italien, G. J. (2005) The metabolic syndrome and schizophrenia: a review. Int. Rev. Psychiatry 17, 173–180.
Miller, L. J., Finnerty, M. (1996) Sexuality, pregnancy, and childrearing among women with schizophrenia-spectrum disorders. Psychiatr. Serv. 47, 502–506.
Millson, R. C., Smith, A. P., Koczapski, A. B., et al. (1993) Self-induced water intoxication treated with group psychotherapy. Am. J. Psychiatry 150, 825–826.
Mirdal, G. K., Mednick, S. A., Schulsinger, F., Fuchs, F. (1974) Perinatal complications in children of schizophrenic mothers. Acta Psychiatr. Scand. 50, 553–568.
Miyaoka, T., Seno, H., Itoga, M., et al. (2000) Schizophrenia-associated idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). J. Clin. Psychiatry 61, 868–871.
Modrzewska, K. (1980) The offspring of schizophrenic parents in a North Swedish isolate. Clin. Genet. 17, 191–201.
Mohamed, S. N., Merskey, H., Kazarian, S., Disney, T. F. (1982) An investigation of the possible inverse relationships between the occurrence of rheumatoid arthritis, osteoarthritis and schizophrenia. Can. J. Psychiatry 27, 381–383.
Mokdad, A. H., Ford, E. S., Bowman, B. A., et al. (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. J. Am. Med. Assoc. 289, 76–79.
Monti, J. M., Monti, D. (2004) Sleep in schizophrenia patients and the effects of antipsychotic drugs. Sleep Med. Rev. 8, 133–148.
Morley, J. E., Shafer, R. B. (1982) Thyroid function screening in new psychiatric admissions. Arch. Intern. Med. 142, 591–593.
Mors, O., Mortensen, P. B., Ewald, H. (1999) A population-based register study of the association between schizophrenia and rheumatoid arthritis. Schizophr. Res. 40, 67–74.
Mortensen, P. B. (1987) Neuroleptic treatment and other factors modifying cancer risk in schizophrenic patients. Acta Psychiatr. Scand. 75, 585–590.
Mortensen, P. B. (1989) The incidence of cancer in schizophrenic patients. J. Epidemiol. Commun. Health 43, 43–47.
Mortensen, P. B. (1992) Neuroleptic medication and reduced risk of prostate cancer in schizophrenic patients. Acta Psychiatr. Scand. 85, 390–393.
Mortensen, P. B. (1994) The occurrence of cancer in first admitted schizophrenic patients. Schizophr. Res. 12, 185–194.
Mukherjee, S., Decina, P., Bocola, V., Saraceni, F., Scapicchio, P. L. (1996) Diabetes mellitus in schizophrenic patients. Compr. Psychiatry 37, 68–73.
Muller, N., Schiller, P., Ackenheil, M. (1991) Coincidence of schizophrenia and hyperbilirubinemia. Pharmacopsychiatry 24, 225–228.
Munck-Jorgensen, P., Mors, O., Mortensen, P. B., Ewald, H. (2000) The schizophrenic patient in the somatic hospital. Acta Psychiatr. Scand. (Suppl.) 102, 96–99.
Muntjewerff, J. W., Blom, H. J. (2005) Aberrant folate status in schizophrenic patients: what is the evidence? Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 1133–1139.
Murphy, G. M., Jr., Lim, K. O., Wieneke, M., et al. (1998) No neuropathologic evidence for an increased frequency of Alzheimer's disease among elderly schizophrenics. Biol. Psychiatry 43, 205–209.
Naber, D., Pajonk, F. G., Perro, C., Lohmer, B. (1994) Human immunodeficiency virus antibody test and seroprevalence in psychiatric patients. Acta Psychiatr. Scand. 89, 358–361.
Naidoo, U., Goff, D. C., Klibanski, A. (2003) Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents. Psychoneuroendocrinology 28 (Suppl. 2), 97–108.
Nakamura, Y., Koh, M., Miyoshi, E., et al. (2004) High prevalence of the hepatitis C virus infection among the inpatients of schizophrenia and psychoactive substance abuse in Japan. Prog. Neuropsychopharmacol. Biol. Psychiatry 28, 591–597.
Nakane, Y., Ohta, Y. (1986) The example of linkage with a cancer register. In Psychiatric Case Registers in Public Health, eds. G. H. Ten Horn, R. Giel, W. H. Gulbinat. Amsterdam: Elsevier, pp. 240–245.
National Heart, Lung and Blood Institute (2001) Definition of Hypertension. Available online at www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=pubmed
National Institutes of Health (2004) Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27, 596–601.
Negulici, E., Christodorescu, D. (1967) Paranoid schizophrenia and Klinefelter's syndrome. Psychiatr. Neurol. (Basel) 154, 27–36.
Neimeier, R., Hauser, G. A., Keller, M., et al. (1959) [Pathological lactation.] Schweiz. Med. Wochenschr. 89, 442–445.
Newcomer, J. W. (2005) Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. central nervous system Drugs 19 (Suppl. 1), 1–93.
Newcomer, J. W., Haupt, D. W., Fucetola, R., et al. (2002) Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch. Gen. Psychiatry 59, 337–345.
Newman, S. C., Bland, R. C. (1991) Mortality in a cohort of patients with schizophrenia: a record linkage study. Can. J. Psychiatry 36, 239–245.
Nicholson, G., Liebling, L. I., Hall, R. A. (1976) Thyroid dysfunction in female psychiatric patients. Br. J. Psychiatry 129, 236–238.
Nilsson, E., Lichtenstein, P., Cnattingius, S., Murray, R. M., Hultman, C. M. (2002) Women with schizophrenia: pregnancy outcome and infant death among their offspring. Schizophr. Res. 58, 221–229.
Nissen, H. A., Spencer, K. A. (1936) The psychogenic problem (endocrinal and metabolic) in chronic arthritis. N. Engl. J. Med. 21, 567–581.
Nordenberg, J., Fenig, E., Landau, M., Weizman, R., Weizman, A. (1999) Effects of psychotropic drugs on cell proliferation and differentiation. Biochem. Pharmacol. 58, 1229–1236.
Nyback, H., Wiesel, F. A., Berggren, B. M., Hindmarsh, T. (1982) Computed tomography of the brain in patients with acute psychosis and in healthy volunteers. Acta Psychiatr. Scand. 65, 403–414.
O'Keane, V., Meaney, A. M. (2005) Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia? J. Clin. Psychopharmacol. 25, 26–31.
Ohta, Y., Nakane, Y., Mine, M., et al. (1988) The epidemiological study of physical morbidity in schizophrenics. 2. Association between schizophrenia and incidence of tuberculosis. Jpn. J. Psychiatry Neurol. 42, 41–47.
Oken, R. J., Schulzer, M. (1999) At issue: schizophrenia and rheumatoid arthritis – the negative association revisited. Schizophr. Bull. 25, 625–638.
Okura, M., Morii, S. (1986) Polydipsia, polyuria and water intoxication observed in psychiatric inpatients. Tokushima J. Exp. Med. 33, 1–5.
Osborn, D. P., King, M. B., Nazareth, I. (2003) Participation in screening for cardiovascular risk by people with schizophrenia or similar mental illnesses: cross sectional study in general practice. Br. Med. J. 326, 1122–1123.
Ostbye, T., Curtis, L. H., Masselink, L. E., et al. (2005) Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study. Pharmacoepidemiol. Drug Saf. 14, 407–415.
Osterberg, E. (1978) Schizophrenia and rheumatic disease: a study on the concurrence of inflammatory joint diseases and a review of 58 case-records. Acta Psychiatr. Scand. 58, 339–359.
Osterlind, A. (1990) Malignant melanoma in Denmark: occurrence and risk factors. Acta Oncol. 29, 833–854.
Othman, S. S., Abdul, K. K., Hassan, J., et al. (1994) High prevalence of thyroid function test abnormalities in chronic schizophrenia. Aust. N. Z. J. Psychiatry 28, 620–624.
Oxenstierna, G., Bergstrand, G., Bjerkenstedt, L., Sedvall, G., Wik, G. (1984) Evidence of disturbed cerebrospinal fluid circulation and brain atrophy in cases of schizophrenic psychosis. Br. J. Psychiatry 144, 654–661.
Paffenberger R. S., Steinmetz, C. H., Pooler, B. G., Hyde, R. T. (1961) The picture puzzle of the postpartum psychosis. J. Chronic Dis. 13, 161–173.
Palmer, B. A., Pankratz, V. S., Bostwick, J. M. (2005) The lifetime risk of suicide in schizophrenia: a re-examination. Arch. Gen. Psychiatry 62, 247–253.
Paton, C., Esop, R., Young, C., Taylor, D. (2004) Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs. Acta Psychiatr. Scand. 110, 299–305.
Peh, L. H., Devan, G. S., Eu, P. W. (1990) Water intoxication in psychiatric patients in Singapore. Singapore Med. J. 31, 238–241.
Pelissolo, A. (1997) [Epidemiology of psychopathologic disorders in infectious diseases.] Encephale 23, (Spec. No. 5), 3–8.
Perisic, V. N., Lopicic, Z., Kokai, G. (1990) Celiac disease and schizophrenia: family occurrence. J. Pediatr. Gastroenterol. Nutr. 11, 279.
Perkins, D. O. (2003) Prolactin- and endocrine-related disorders in schizophrenia. In Medical Illness and Schizophrenia, eds. J. M. Meyer, H. A. Nasrallah. Washington, DC: American Psychiatric Publishing, pp. 215–232.
Pilkington, T. L. (1956) The coincidence of rheumatoid arthritis and schizophrenia. J. Nerv. Ment. Dis. 124, 604–606.
Preti, A., Cardascia, L., Zen, T., et al. (2000) Risk for obstetric complications and schizophrenia. Psychiatr. Res. 96, 127–139.
Primatesta, P., Hirani, V. (1999) Health Survey for England: The Health of Minority Ethnic Groups. 1999. London: Department of Health. http://www.official-documents.co.uk. 2007.
Prohovnik, I., Dwork, A. J., Kaufman, M. A. Willson, N. (1993) Alzheimer-type neuropathology in elderly schizophrenia patients. Schizophr. Bull. 19, 805–816.
Pryce, I. G., Edwards, H. (1966) Persistent oral dyskinesia in female mental hospital patients. Br. J. Psychiatry 112, 983–987.
Py, O., Mathieu, P. (1960) [Galactorrhea and disorders of the menstrual cycle in the course of neuroleptic treatments.] Presse Med. 68, 765–766.
Qin, P., Xu, H., Laursen, T. M., Vestergaard, M., Mortensen, P. B. (2005) Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy: population-based cohort study. Br. Med. J. 331, 23.
Ragins, N., Schachter, J., Elmer, E., et al. (1975) Infants and children at risk for schizophrenia: environmental and developmental observations. J. Am. Acad. Child Psychiatry 14, 150–177.
Ramsay, R. A., Ananth, J., Engelsmann, F., et al. (1982) Schizophrenia and psychosomatic illness. J. Psychosom. Res. 26, 33–42.
Ravichand, D. M., Sheshayamma, V., Lakshmi Kameshwari, V., Chakradhar, T. (2005) Thyroid hormones and antithyroid drugs. Calicut Med. J. 3, e3.
Ray, W. A., Meredith, S., Thapa, P. B., et al. (2001) Antipsychotics and the risk of sudden cardiac death. Arch. Gen. Psychiatry 58, 1161–1167.
Regenold, W. T., Thapar, R. K., Marano, C., Gavirneni, S., Kondapavuluru, P. V. (2002) Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J. Affect. Disord. 70, 19–26.
Reilly, J. G., Ayis, S. A., Ferrier, I. N., Jones, S. J., Thomas, S. H. (2000) QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 355, 1048–1052.
Rieder, R. O., Rosenthal, D., Wender, P., Blumenthal, H. (1975) The offspring of schizophrenics. 1. Fetal and neonatal deaths. Arch. Gen. Psychiatry 32, 200–211.
Rieder, R. O., Broman, S. H., Rosenthal, D. (1977) The offspring of schizophrenics. 2. Perinatal factors and IQ. Arch. Gen. Psychiatry 34, 789–799.
Riggs, A. T., Dysken, M. W., Kim, S. W., Opsahl, J. A. (1991) A review of disorders of water homeostasis in psychiatric patients. Psychosomatics 32, 133–148.
Rimon, R., Halonen, P., Puhakka, P., et al. (1979) Immunoglobulin G antibodies to herpes simplex type 1 virus detected by radioimmunoassay in serum and cerebrospinal fluid of patients with schizophrenia. J. Clin. Psychiatry 40, 241–243.
Riscalla, L. M. (1980) Blindness and schizophrenia. Med. Hypotheses 6, 1327–1328.
Robins, A. H. (1972) Phenothiazine melanosis in schizophrenic patients. Psychopharmacologia 27, 327–342.
Roca, R. P., Blackman, M. R., Ackerley, M. B., Harman, S. M., Gregerman, R. I. (1990) Thyroid hormone elevations during acute psychiatric illness: relationship to severity and distinction from hyperthyroidism. Endocr. Res. 16, 415–447.
Rodgers-Johnson, P. E., Hickling, F. W., Irons, A., et al. (1996) Retroviruses and schizophrenia in Jamaica. Mol. Chem. Neuropathol. 28, 237–243.
Rose, D. P., Pruitt, B. T. (1981) Plasma prolactin levels in patients with breast cancer. Cancer 48, 2687–2691.
Rosenberg, S. D., Goodman, L. A., Osher, F. C., et al.(2001) Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C in people with severe mental illness. Am. J. Public Health 91, 31–37.
Rosenthal, S. H., Porter, K. A., Coffey, B. (1990) Pain insensitivity in schizophrenia: case report and review of the literature. Gen. Hosp. Psychiatry 12, 319–322.
Ross, W. D., Hay, J., McDowall, M. F. (1950) The association of certain vegetative disturbances with various psychoses. Psychosom. Med. 12, 170–183.
Rothermich, N. O., Philips, V. K. (1963) Rheumatoid arthritis in criminal and mentally ill populations. Arthritis Rheum. 6, 639–640.
Rotkin, I. D. (1977) Studies in the epidemiology of prostatic cancer: expanded sampling. Cancer Treat. Rep. 61, 173–180.
Ruigomez, A., Garcia Rodriguez, L. A., Dev, V. J., Arellano, F., Raniwala, J. (2000) Are schizophrenia or antipsychotic drugs a risk factor for cataracts? Epidemiology 11, 620–623.
Rwegellara, G. G. C., Mambwe, C. C. (1977) Psychiatric status and disorders of thyroid-function. 1. Prevalence of goiter in a group of psychiatric patients. Med. J. Zambia 11, 78–83.
Ryan, M. C., Collins, P., Thakore, J. H. (2003) Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am. J. Psychiatry 160, 284–289.
Ryan, W. G., Roddam, R. F., Grizzle, W. E. (1994) Thyroid function screening in newly admitted psychiatric inpatients. Ann. Clin. Psychiatry 6, 7–12.
Rybakowski, J., Romanski, B., Dabkowska, M., Grabowski, P., Krymer, A. (1992) Allergic skin reactions in schizophrenia and affective disorders. Biol. Psychiatry 31, 1181–1182.
Saari, K. M., Jokelainen, J., Veijola, J., et al. (2004) Serum lipids in schizophrenia and other functional psychoses: a general population northern Finland 1966 birth cohort survey. Acta Psychiatr. Scand. 110, 279–285.
Saari, K. M., Lindeman, S. M., Viilo, K. M., et al. (2005) A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 Birth Cohort study. J. Clin. Psychiatry 66, 559–563.
Sachdev, P. S. (1998) Schizophrenia-like psychosis and epilepsy: the status of the association. Am. J. Psychiatry 155, 325–336.
Sachdev, P. S. (2000) The current status of tardive dyskinesia. Aust. N. Z. J. Psychiatry 34, 355–369.
Sacker, A., Done, D. J., Crow, T. J. (1996) Obstetric complications in children born to parents with schizophrenia: a meta-analysis of case-control studies. Psychol. Med. 26, 279–287.
Sacks, M. H., Dermatis, H., Looser-Ott, S., Burton, W., Perry, S. (1992) Undetected human immunodeficiency virus infection among acutely ill psychiatric inpatients. Am. J. Psychiatry 149, 544–545.
Sacks, M. H., Silberstein, C., Weiler, P., Perry, S. (1990) human immunodeficiency virus-related risk factors in acute psychiatric inpatients. Hosp. Commun. Psychiatry 41, 449–451.
Said, W. M., Saleh, R., Jumaian, N. (2001) Prevalence of hepatitis B virus among chronic schizophrenia patients. East Mediterr. Health J. 7, 526–530.
Sameroff, A. J., Zax, M. (1973) Perinatal characteristics of the offspring of schizophrenic women. J. Nerv. Ment. Dis. 157, 191–199.
Sandison, R. A., Whitelaw, E., Currie, J. D. (1960) Clinical trials with melleril (TP21) in the treatment of schizophrenia: a two-year study. J. Ment. Sci. 106, 732–741.
Sartorius, N., Schulze, H. (eds.) (2005) A Report of a Global Programme of the World Psychiatric Association, eds. N. Sartorius, H. Schulze. Cambridge, UK: Cambridge University Press.
Scheflen, A. E. (1951) Malignant tumors in the institutionalized psychotic population. Arch. Neurol. Psychiatry 66, 145–155.
Schneider, K. (1959) Clinical Psychopathology. New York: Grune & Stratton.
Schubert, E. W., McNeil, T. F. (2004) Prospective study of neurological abnormalities in offspring of women with psychosis: birth to adulthood. Am. J. Psychiatry 161, 1030–1037.
Schubert, E. W., Blennow, G., McNeil, T. F. (1996) Wakefulness and arousal in neonates born to women with schizophrenia: diminished arousal and its association with neurological deviations. Schizophr. Res. 22, 49–59.
Schwalb, H. (1975) [Risk factors of coronary heart diseases in hospitalized psychic patients.] Munch. Med. Wochenschr. 117, 1181–1188.
Schwalb, H., van Eimeren, W., Friedrich, H. V. (1976) [The risk of heart disease in various psychiatric diseases.] Z. Kardiol. 65, 1115–1123.
Schwartz-Watts, D., Montgomery, L. D., Morgan, D. W. (1995) Seroprevalence of human immunodeficiency virus among inpatient pretrial detainees. Bull. Am. Acad. Psychiatr. Law 23, 285–288.
Secreto, G., Recchione, C., Cavalleri, A., Miraglia, M., Dati, V. (1983) Circulating levels of testosterone, 17 beta-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients. Br. J. Cancer 47, 269–275.
Seeman, M. V., Lang, M., Rector, N. (1990) Chronic schizophrenia: a risk factor for human immunodeficiency virus? Can. J. Psychiatry 35, 765–768.
Sewell, D. D. (1996) Schizophrenia and human immunodeficiency virus. Schizophr. Bull. 22, 465–473.
Shader, R. I., Grinspoon, L. (1970) The effect of social feedback on chronic schizophrenic patients. Compr. Psychiatry 11, 196–199.
Shah, P. J., Greenberg, W. M. (1992) Polydipsia with hyponatremia in a state hospital population. Hosp. Commun. Psychiatry 43, 509–511.
Shinmoto, M., Kawarabayashi, T., Sugimori, H., et al. (1989) [The obstetric prognosis and neonatal outcome of pregnant women with psychiatric disorders.] Nippon Sanka Fujinka Gakkai Zasshi 41, 1965–1971.
Sibai, B. M., Gordon, T., Thom, E., et al. (1995) Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study – The National Institute of Child Health and Human Development Network of Maternal–Fetal Medicine Units. Am. J. Obstet. Gynecol. 172, 642–648.
Sicree, R., Shaw, J., Zimmet, P. (2003) The global burden of diabetes. In Diabetes Atlas, ed D. Gan. Brussels: International Diabetes Federation, pp. 15–71.
Silberstein, C., Galanter, M., Marmor, M., et al. (1994) human immunodeficiency virus-1 among inner city dually diagnosed inpatients. Am. J. Drug Alcohol Abuse 20, 101–113.
Silver, H., Kogan, H., Zlotogorski, D. (1990) Postural hypotension in chronically medicated schizophrenics. J. Clin. Psychiatry 51, 459–462.
Silverstone, T., Smith, G., Goodall, E. (1988) Prevalence of obesity in patients receiving depot antipsychotics. Br. J. Psychiatry 153, 214–217.
Sim, K., Chong, S. A., Chan, Y. H., Lum, W. M. (2002) Thyroid dysfunction in chronic schizophrenia within a state psychiatric hospital. Ann. Acad. Med. Singapore 31, 641–644.
Singh, M. K., Giles, L. L., Nasrallah, H. A. (2006) Pain insensitivity in schizophrenia: trait or state marker? J. Psychiatr. Pract. 12, 90–102.
Singh, M. M., Kay, S. R. (1976) Wheat gluten as a pathogenic factor in schizophrenia. Science 191, 401–402.
Siscovick, D. S., Raghunathan, T. E., Psaty, B. M., et al. (1994) Diuretic therapy for hypertension and the risk of primary cardiac arrest. N. Engl. J. Med. 330, 1852–1857.
Sleeper, F. H. (1935) Investigation of polyuria in schizophrenia. Am. J. Psychiatry 91, 1019–1031.
Smith, S. M., O'Keane, V., Murray, R. (2002) Sexual dysfunction in patients taking conventional antipsychotic medication. Br. J. Psychiatry 181, 49–55.
Sobel, D. E. (1961) Children of schizophrenic patients: preliminary observations on early development. Am. J. Psychiatry 118, 512–517.
Spector, T. D. (1990) Rheumatoid arthritis. Rheum. Dis. Clin. North Am. 16, 513–537.
Spratt, D. I., Pont, A., Miller, M. B., et al. (1982) Hyperthyroxinemia in patients with acute psychiatric disorders. Am. J. Med. 73, 41–48.
Stanley, H. L., Schmitt, B. P., Poses, R. M., Deiss, W. P. (1991) Does hypogonadism contribute to the occurrence of a minimal trauma hip tracture in elderly men? J. Am. Geriatr. Soc. 39, 766–771.
Steiner, I., Abramsky, O. (1989) Autoimmune diseases of the neuroimmune system and mental disease. Immunol. Ser. 45, 491–511.
Steinert, T., Wolfersdorf, M., Thoma, H., Marpert, M. (1996) [Does long-term hospitalization modify cardiovascular morbidity in schizophrenic patients?] Fortschr. Neurol. Psychiatr. 64, 212–220.
Stevens, F. M., Lloyd, R. S., Geraghty, S. M., et al. (1977) Schizophrenia and coeliac disease: the nature of the relationship. Psychol. Med. 7, 259–263.
Stewart, D. L., Zuckerman, C. J., Ingle, J. M. (1994) human immunodeficiency virus seroprevalence in a chronically mentally ill population. J. Natl Med. Assoc. 86, 519–523.
Subramaniam, M., Chong, S. A., Pek, E. (2003) Diabetes mellitus and impaired glucose tolerance in patients with schizophrenia. Can. J. Psychiatry 48, 345–347.
Sugerman, A. A., Southern, D. L., Curran, J. F. (1982) A study of antibody levels in alcoholic, depressive and schizophrenic patients. Ann. Allergy 48, 166–171.
Susser, E., Valencia, E., Conover, S. (1993) Prevalence of human immunodeficiency virus infection among psychiatric patients in a New York City men's shelter. Am. J. Public Health 83, 568–570.
Sweetwood, H. L., Kripke, D. F., Grant, I., Yager, J., Gerst, M. S. (1976) Sleep disorder and psychobiological symptomatology in male psychiatric outpatients and male nonpatients. Psychosom. Med. 38, 373–378.
Taieb, O., Baleyte, J. M., Mazet, P., Fillet, A. M. (2001) Borna disease virus and psychiatry. Eur. Psychiatry 16, 3–10.
Takahashi, K. I., Shimizu, T., Sugita, T., (1998) Prevalence of sleep-related respiratory disorders in 101 schizophrenic inpatients. Psychiatr. Clin. Neurosci. 52, 229–231.
Tang, W. K., Sun, F. C., Ungvari, G. S., O'Donnell, D. (2004) Oral health of psychiatric in-patients in Hong Kong. Int. J. Soc. Psychiatry 50, 186–191.
Taylor, D. C. (2003) Schizophrenias and epilepsies: why? when? how? Epilepsy Behav. 4, 474–482.
Taylor, S. (1984) Gilbert's syndrome as a cause of postoperative jaundice. Anaesthesia 39, 1222–1224.
Templer, D. I., Cappelletty, G. G., Kauffman, I. (1988) Schizophrenia and multiple sclerosis: distribution in Italy. Br. J. Psychiatry 153, 389–390.
Templer, D. I., Regier, M. W., Corgiat, M. D. (1985) Similar distribution of schizophrenia and multiple sclerosis. J. Clin. Psychiatry 46, 73.
Terenius, L., Wahlstrom, A. (1978) Physiologic and clinical relevance of endorphins. In Centrally Acting Peptides, ed. J. Hughes Baltimore, MD: Baltimore University Park Press, pp. 161–178.
Test, M. A., Wallisch, L. S., Allness, D. J., Ripp, K. (1989) Substance abuse in young adults with schizophrenic disorders. Schizophr. Bull. 15, 465–476.
Teunissen, C. E., de Vente, J., Steinbusch, H. W., De Bruijn, C. (2002) Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid. Neurobiol. Aging 23, 485–508.
Thakore, J. H., Mann, J. N., Vlahos, I., Martin, A., Reznek, R. (2002) Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia. Int. J. Obes. Relat Metab. Disord. 26, 137–141.
Theisen, F. M., Linden, A., Geller, F., et al. (2001) Prevalence of obesity in adolescent and young adult patients with and without schizophrenia and in relationship to antipsychotic medication. J. Psychiatr. Res. 35, 339–345.
Thomas, A., Lavrentzou, E., Karouzos, C., Kontis, C. (1996) Factors which influence the oral condition of chronic schizophrenia patients. Spec. Care Dentist 16, 84–86.
Tishler, P. V., Woodward, B., O'Connor, J., et al. (1985) High prevalence of intermittent acute porphyria in a psychiatric patient population. Am. J. Psychiatry 142, 1430–1436.
Torrey, E. F. (1979) Headaches after lumbar puncture and insensitivity to pain in psychiatric patients. N. Engl. J. Med. 301, 110.
Torrey, E. F. (1997) Out of the Shadows: Confronting America's Mental Illness Crisis. New York: John Wiley.
Torrey, E. F., Peterson, M. R. (1973) Slow and latent viruses in schizophrenia. Lancet ⅱ, 22–24.
Torrey, E. F., Yolken, R. H. (2001) The schizophrenia–rheumatoid arthritis connection: infectious, immune, or both? Brain Behav. Immun. 15, 401–410.
Torrey, E. F., Yolken, R. H. (2003) Toxoplasma gondii and schizophrenia. Emerg. Infect. Dis. 9, 1375–1380.
Trevathan, R. D., Tatum, J. C. (1954) Rarity of occurrence of psychosis and rheumatoid arthritis in individual patients. J. Nerv. Ment. Dis. 120, 83–84.
Tsuang, M. T., Fleming, J. A., Simpson, J. C. (1999) Suicide and schizophrenia. In The Harvard Medical School Guide to Suicide Assessment and Intervention, ed. D. G. Jacobs. San Francisco, CA: Jossey-Bass, pp. 287–299
Turkington, R. W. (1972) Prolactin secretion in patients treated with various drugs: phenothiazines, tricyclic antidepressants, reserpine, and methyldopa. Arch. Intern. Med. 130, 349–354.
Ural, S. (2004) What is the Apgar score? Available online at www.kidshealth.org/parent/newborn/first_days/apgar.html
Varsamis, J., Adamson, J. D. (1976) Somatic symptoms in schizophrenia. Can. Psychiatr. Assoc. J. 21, 1–6.
Velasco, E., Machuca, G., Martinez-Sahuquillo, A., et al. (1997) Dental health among institutionalized psychiatric patients in Spain. Spec. Care Dentist 17, 203–206.
Velasco-Ortega, E., Monsalve-Guil, L., Velasco-Ponferrada, C., Medel-Soteras, R., Segura-Egea, J. J. (2005) Temporomandibular disorders among schizophrenic patients: a case-control study. Med. Oral Patol. Oral Cir. Bucal. 10, 315–322.
Vieweg, W. V., David, J. J., Glick, J. L., et al. (1986) Polyuria among patients with psychosis. Schizophr. Bull. 12, 739–743.
Vieweg, W. V., David, J. J., Rowe, W. T., et al. (1985) Death from self-induced water intoxication among patients with schizophrenic disorders. J. Nerv. Ment. Dis. 173, 161–165.
Viskum, K. (1975) Mind and ulcer. Acta Psychiatr. Scand. 51, 182–200.
Volavka, J., Convit, A., Czobor, P., et al. (1991) human immunodeficiency virus seroprevalence and risk behaviors in psychiatric inpatients. Psychiatr. Res. 39, 109–114.
Wainberg, M. L., Cournos, F., McKinnon, K., Berkman, A. (2003) human immunodeficiency virus and hepatitis C in patients with schizophrenia. In Medical Illness and Schizophrenia, eds. J. M. Meyer, H. A. Nasrallah. Washington, DC: American Psychiatric Publishing, pp. 115–140.
Warner, J. P., Barnes, T. R., Henry, J. A. (1996) Electrocardiographic changes in patients receiving neuroleptic medication. Acta Psychiatr. Scand. 93, 311–313.
Watson, G. D., Chandarana, P. C., Merskey, H. (1981) Relationships between pain and schizophrenia. Br. J. Psychiatry 138, 33–36.
Webb, R., Abel, K., Pickles, A., Appleby, L. (2005) Mortality in offspring of parents with psychotic disorders: a critical review and meta-analysis. Am. J. Psychiatry 162, 1045–1056.
Weinberg, A. D., Katzell, T. D. (1977) Thyroid and adrenal function among psychiatric patients. Lancet ⅰ, 1104–1105.
Weinreb, M., Kraus, V., Krausova, J., Hudcova, T. (1978) Negligible hepatotoxicity of chlorpromazine in long-term therapy. Acta. Nerv. Super. (Praha) 20, 280–281.
Wesselmann, U., Windgassen, K. (1995) Galactorrhea: subjective response by schizophrenic patients. Acta Psychiatr. Scand. 91, 152–155.
Wetterling, T., Pest, S., Mussigbrodt, H., Weber, B. (2004) [Bodyweight in inpatients with schizophrenia.] Psychiatr. Prax. 31, 250–254.
White, K. E., Cummings, J. L. (1996) Schizophrenia and Alzheimer's disease: clinical and pathophysiologic analogies. Compr. Psychiatry 37, 188–195.
Wieck, A., Haddad, P. M. (2003) Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences – selective literature review. Br. J. Psychiatry 182, 199–204.
Wiedorn, W. S. (1954) Toxemia of pregnancy and schizophrenia. J. Nerv. Ment. Dis. 120, 1–9.
Windgassen, K., Wesselmann, U., Schulze, M. H. (1996) Galactorrhea and hyperprolactinemia in schizophrenic patients on neuroleptics: frequency and etiology. Neuropsychobiology 33, 142–146.
Winkelman, J. W. (2001) Schizophrenia, obesity, and obstructive sleep apnea. J. Clin. Psychiatry 62, 8–11.
Wolff, A. L., O'Driscoll, G. A. (1999) Motor deficits and schizophrenia: the evidence from neuroleptic-naive patients and populations at risk. J. Psychiatr. Neurosci. 24, 304–314.
World Health Organization (1992) International Statistical Classification of Diseases and Related Health Problems, 10th revn. Geneva: World Health Organization.
World Health Organization (1999) Report of a WHO Consultation: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part I: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization.
World Health Organization (2001) World Health Report 2001: Mental Health – New Understanding, New Hope. Geneva: World Health Organization.
World Health Organization (2004) human immunodeficiency virus and acquired immundeficiency syndrome Statistics and Features, End of 2002 and 2004. Available online at www.unaids.org/wad2004/EPIupdate2004_html_en/Epi04_12_en.htm#P227_67386
Wrede, G., Mednick, S. A., Huttunen, M. O., Nilsson, C. G. (1980) Pregnancy and delivery complications in the births of an unselected series of Finnish children with schizophrenic mothers. Acta Psychiatr. Scand. 62, 369–381.
Yase, Y., Matsumoto, N., Azuma, K., Nakai, Y., Shiraki, H. (1972) Amyotrophic lateral sclerosis: association with schizophrenic symptoms and showing Alzheimer's tangles. Arch. Neurol. 27, 118–128.
Young, T., Palta, M., Dempsey, J., et al. (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med. 328, 1230–1235.
Zamperetti, M., Goldwurm, G. F., Abbate, E., et al. (1990) Attempted suicide and human immunodeficiency virus infection: epidemiological aspects in a psychiatric ward. International Conference on acquired immundeficiency syndrome, San Francisco, CA.
Zaridze, D. G., Boyle, P. (1987) Cancer of the prostate: epidemiology and aetiology. Br. J. Urol. 59, 493–502.
Zax, M., Sameroff, A. J., Babigian, H. M. (1977) Birth outcomes in the offspring of mentally disordered women. Am. J. Orthopsychiatry 47, 218–230.
Zeenreich, A., Gochstein, B., Grinshpoon, A., et al. (1998) [Recurrent tuberculosis in a psychiatric hospital: recurrent outbreaks during 1987–1996.] Harefuah 134, 168–172, 248, 247.
Zhang-Wong, J. H., Seeman, M. V. (2002) Antipsychotic drugs, menstrual regularity and osteoporosis risk. Arch. Women Ment. Health 5, 93–98.
Zimmet, P. (2005) Epidemiology of diabetes mellitus and associated cardiovascular risk factors: focus on human immunodeficiency virus and psychiatric disorders. Am. J. Med. 118 (Suppl. 2), 3S-8S.
Zito, J. M., Sofair, J. B., Jaeger, J. (1990) Self-reported neuroendocrine effects of antipsychotics in women: a pilot study. Drug Intell. Clin. Pharmacy 24, 176–180.